Changes in HbA1c and Weight Following Transition to Continuous Subcutaneous Insulin Infusion Therapy in Adults with Type 1 Diabetes

Journal of Diabetes Science and Technology

Volumn 11, Issue 1, 2017, Pages 83-86

  Mehta, Sanjeev N ^a   Andersen, Henrik Ullits ^b   Abrahamson, Martin J ^c   Wolpert, Howard A ^a   Hommel, Eva E ^b   McMullen, William ^a   Ridderstråle, Martin ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b STENO DIABETES CENTER   (Denmark)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

continuous subcutaneous insulin infusion; HbA1c; insulin pumps; type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; DENMARK; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; TREATMENT OUTCOME; UNITED STATES; WEIGHT GAIN; ADOLESCENT; AGED; BLOOD; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; MIDDLE AGED; TRANSITION TO ADULT CARE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DENMARK; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; TRANSITION TO ADULT CARE; UNITED STATES; WEIGHT GAIN; YOUNG ADULT;

EID: 85009277262     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296816658900     Document Type: Article

References (13)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329 (14): 977-986.
2. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353 (25): 2643-2653.
3. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J,. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010 (1): CD005103.
4. Maiorino MI, Bellastella G, Petrizzo M, et al. Treatment satisfaction and glycemic control in young type 1 diabetic patients in transition from pediatric health care: CSII versus MDI. Endocrine. 2014; 46 (2): 256-262.
5. Pickup JC, Sutton AJ., Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008; 25 (7): 765-774.
6. Retnakaran R, Hochman J, DeVries JH, et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care. 2004; 27 (11): 2590-2596.
7. Lepore G, Dodesini AR, Nosari I, Trevisan R., Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes Care. 2003; 26 (4): 1321-1322.
8. Bruttomesso D, Pianta A, Crazzolara D, et al. Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabet Med. 2002; 19 (8): 628-634.
9. Mameli C, Scaramuzza AE, Ho J, Cardona-Hernandez R, Suarez-Ortega L, Zuccotti GV., A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes. Acta Diabetologica. 2014; 51 (2): 205-210.
10. Clements M, Matuleviciene V, Attvall S, et al. Predicting the effectiveness of insulin pump therapy on glycemic control in clinical practice: a retrospective study of patients with type 1 diabetes from 10 outpatient diabetes clinics in Sweden over 5 years. Diabetes Technol Ther. 2015; 17 (1): 21-28.
11. Joubert M, Morera J, Vicente A, Rod A, Parienti JJ, Reznik Y., Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment. J Diabetes Sci Technol. 2014; 8 (5): 1005-1010.
12. Cohen ND, Hong ES, Van Drie C, Balkau B, Shaw J., Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes. Diabetes Technol Ther. 2013; 15 (7): 544-549.
13. Pozzilli P, Crino A, Schiaffini R, et al. A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). Diabetes Technol Ther. 2003; 5 (6): 965-974.